{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:15:32Z","timestamp":1790720132247,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["CS-2013-13-032"],"award-info":[{"award-number":["CS-2013-13-032"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/jid.2015.317","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T13:55:35Z","timestamp":1439992535000},"page":"2935-2943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["IFN\u03bb Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism"],"prefix":"10.1016","volume":"135","author":[{"given":"Adewonuola A.","family":"Alase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser M.","family":"El-Sherbiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond J.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2015.317_bb0010","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00262-010-0831-3","article-title":"Antitumor activity of type I and type III interferons in BNL hepatoma model","volume":"59","author":"Abushahba","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1038\/jid.2015.317_bb0015","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.4049\/jimmunol.180.4.2474","article-title":"An important role for type III interferon (IFN-lambda\/IL-28) in TLR-induced antiviral activity","volume":"180","author":"Ank","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/jid.2015.317_bb0020","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bcp.2012.11.004","article-title":"IFNalpha converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets","volume":"85","author":"Bachmann","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1038\/jid.2015.317_bb0025","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.26657","article-title":"Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression","volume":"59","author":"Bolen","year":"2014","journal-title":"Hepatology"},{"key":"10.1038\/jid.2015.317_bb0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/mi.2012.41","article-title":"IFN-gamma and TNF-alpha-induced GBP-1 inhibits epithelial cell proliferation through suppression of beta-catenin\/TCF signaling","volume":"5","author":"Capaldo","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1038\/jid.2015.317_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11033-010-0087-1","article-title":"IL-29 and IFN-alpha regulate the expression of MxA, 2\u2032,5\u2032-OAS and PKR genes in association with the activation of Raf-MEK-ERK and PI3K-AKT signal pathways in HepG2.2.15 cells","volume":"38","author":"Chai","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1038\/jid.2015.317_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(03)00439-3","article-title":"Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38","volume":"546","author":"Clark","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1038\/jid.2015.317_bb0045","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1182\/blood-2008-09-179507","article-title":"IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells","volume":"113","author":"Dai","year":"2009","journal-title":"Blood"},{"key":"10.1038\/jid.2015.317_bb0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1189\/jlb.0812395","article-title":"Interferon-lambda (IFN-lambda) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes","volume":"93","author":"Dickensheets","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1038\/jid.2015.317_bb0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1084\/jem.20131557","article-title":"IFN-lambda receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-lambda3 genotype and with nonresponsiveness to IFN-alpha therapies","volume":"211","author":"Duong","year":"2014","journal-title":"J Exp Med"},{"key":"10.1038\/jid.2015.317_bb0060","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/infdis\/jiu144","article-title":"Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus","volume":"210","author":"Egli","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1038\/jid.2015.317_bb0065","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1096\/fj.00-0233com","article-title":"Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts","volume":"15","author":"Eickelberg","year":"2001","journal-title":"FASEB J"},{"key":"10.1038\/jid.2015.317_bb0070","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1074\/jbc.M004709200","article-title":"Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300\/CBP transcriptional coactivators","volume":"276","author":"Ghosh","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2015.317_bb0075","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1093\/emboj\/18.20.5601","article-title":"p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons","volume":"18","author":"Goh","year":"1999","journal-title":"EMBO J"},{"key":"10.1038\/jid.2015.317_bb0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cytogfr.2008.08.004","article-title":"IFNgamma signaling-does it mean JAK-STAT?","volume":"19","author":"Gough","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1038\/jid.2015.317_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0923-1811(03)00044-6","article-title":"IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts","volume":"32","author":"Hasegawa","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1038\/jid.2015.317_bb0090","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/bies.20636","article-title":"The collagen family members as cell adhesion proteins","volume":"29","author":"Heino","year":"2007","journal-title":"BioEssays"},{"key":"10.1038\/jid.2015.317_bb0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cyto.2010.03.019","article-title":"Mechanisms of mRNA translation of interferon stimulated genes","volume":"52","author":"Joshi","year":"2010","journal-title":"Cytokine"},{"key":"10.1038\/jid.2015.317_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2015.317_bb0105","doi-asserted-by":"crossref","first-page":"349575","DOI":"10.1155\/2011\/349575","article-title":"Interferon lambda: a new sword in cancer immunotherapy","volume":"2011","author":"Lasfar","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1038\/jid.2015.317_bb0110","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1074\/jbc.M309927200","article-title":"Role of p38alpha Map kinase in Type I interferon signaling","volume":"279","author":"Li","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2015.317_bb0115","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2010-07-298976","article-title":"IL-29 and IFNalpha differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNgamma receptor expression","volume":"117","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"10.1038\/jid.2015.317_bb0120","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1002\/j.1460-2075.1995.tb00192.x","article-title":"Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster","volume":"14","author":"Lutfalla","year":"1995","journal-title":"EMBO J"},{"key":"10.1038\/jid.2015.317_bb0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri3210","article-title":"Interferon-inducible effector mechanisms in cell-autonomous immunity","volume":"12","author":"MacMicking","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/jid.2015.317_bb0130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4161\/cbt.7.7.6192","article-title":"IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK\/STAT signaling activity","volume":"7","author":"Maher","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1038\/jid.2015.317_bb0135","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1182\/blood-2005-10-4129","article-title":"Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells","volume":"107","author":"Mennechet","year":"2006","journal-title":"Blood"},{"key":"10.1038\/jid.2015.317_bb0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jbspin.2009.03.012","article-title":"Interferons and autoimmune disorders","volume":"76","author":"Meyer","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1038\/jid.2015.317_bb0145","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jmb.2010.09.068","article-title":"Crystal structure of human interferon-lambda1 in complex with its high-affinity receptor interferon-lambdaR1","volume":"404","author":"Miknis","year":"2010","journal-title":"J Mol Biol"},{"key":"10.1038\/jid.2015.317_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0625.2010.01160.x","article-title":"Increased expression of guanylate binding protein-1 in lesional skin of patients with cutaneous lupus erythematosus","volume":"20","author":"Naschberger","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2015.317_bb0155","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/bj3490427","volume":"349","author":"Nguyen","year":"2000","journal-title":"Biochem J"},{"key":"10.1038\/jid.2015.317_bb0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1600-0625.2000.009001053.x","article-title":"Proliferation and effects of UVA irradiation in cultured fibroblasts from lesions in cutaneous lupus erythematosus","volume":"9","author":"Nyberg","year":"2000","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2015.317_bb0165","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1172\/JCI68127","article-title":"Collagen VII plays a dual role in wound healing","volume":"123","author":"Nystrom","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2015.317_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1742-481X.2009.00638.x","article-title":"Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens","volume":"6","author":"Oliveira","year":"2009","journal-title":"Int Wound J"},{"key":"10.1038\/jid.2015.317_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(03)00016-0","article-title":"The p38 mitogen-activated protein kinase pathway and its role in interferon signaling","volume":"98","author":"Platanias","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1038\/jid.2015.317_bb0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2015.317_bb0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"The interferon signature in autoimmune diseases","volume":"25","author":"Ronnblom","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1038\/jid.2015.317_bb0190","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/jid.2015.317_bb0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1038\/jid.2015.317_bb0200","doi-asserted-by":"crossref","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1038\/jid.2015.317_bb0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/jir.2010.0058","article-title":"Interferon-lambda as a potential therapeutic agent in cancer treatment","volume":"30","author":"Steen","year":"2010","journal-title":"J Interferon Cytokine Res"},{"key":"10.1038\/jid.2015.317_bb0210","doi-asserted-by":"crossref","first-page":"27634","DOI":"10.1074\/jbc.M003170200","article-title":"The Rac1\/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins","volume":"275","author":"Uddin","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2015.317_bb0215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","article-title":"Complex modulation of cell type-specific signaling in response to type I interferons","volume":"25","author":"van Boxel-Dezaire","year":"2006","journal-title":"Immunity"},{"key":"10.1038\/jid.2015.317_bb0220","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1365-2133.2005.06784.x","article-title":"Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA","volume":"153","author":"Wenzel","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2015.317_bb0225","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/gene.2009.72","article-title":"Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines","volume":"10","author":"Witte","year":"2009","journal-title":"Genes Immun"},{"key":"10.1038\/jid.2015.317_bb0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cytogfr.2010.04.002","article-title":"IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties","volume":"21","author":"Witte","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1038\/jid.2015.317_bb0235","doi-asserted-by":"crossref","first-page":"204ra129","DOI":"10.1126\/scitranslmed.3006245","article-title":"IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis","volume":"5","author":"Wolk","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1038\/jid.2015.317_bb0240","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-beta-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res"},{"key":"10.1038\/jid.2015.317_bb0245","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.4049\/jimmunol.1102038","article-title":"Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells","volume":"189","author":"Yin","year":"2012","journal-title":"J Immunol"},{"key":"10.1038\/jid.2015.317_bb0250","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1365-2133.2011.10479.x","article-title":"Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus","volume":"165","author":"Zahn","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2015.317_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/jid.2010.244","article-title":"Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNlambda) in cutaneous lupus erythematosus","volume":"131","author":"Zahn","year":"2010","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2015.317_bb0260","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.bbrc.2006.04.043","article-title":"Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells","volume":"344","author":"Zitzmann","year":"2006","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15601658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15601658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T22:19:12Z","timestamp":1743977952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15601658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0022202X15601658"],"URL":"https:\/\/doi.org\/10.1038\/jid.2015.317","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFN\u03bb Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2015.317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}